Proteintech's monoclonal and polyclonal antibodies are now available directly conjugated with fluorescent dyes: CoraLite488, CoraLite594 and CoraLite647. They act as useful tools for immunofluorescence studies requiring multiplex co-labelling studies without the need for secondary antibodies.
ViroStat has released several monoclonal antibodies to the Marburg virus — one of the causes of viral haemorrhagic fever.
GeneTex's SARS-CoV/SARS-CoV-2 (COVID-19) spike antibody [1A9] detects both SARS-CoV spike and SARS-CoV-2 spike proteins.
AdipoGen Life Sciences offers a broad range of microtubule research solutions. This includes tubulin-specific antibodies, unique and validated post-translational modification-specific antibodies and Rab1-GTP and Rab6-GTP specific antibodies.
SYnAbs produces innovative monoclonal antibodies against poor immunogenic compounds and complex antigens.
The ability to accurately characterize the immune response against SARS-CoV-2 is of vital importance in managing the current COVID-19 pandemic.
Diaclone provides a large panel of research tools, monoclonal antibodies and ELISA kits for measuring the levels of released cytokines triggered by viral infection (cytokine release syndrome — CRS).
AdipoGen Life Sciences offers a broad range of Interleukin-33 research solutions, including an IL-33 blocking antibody (available in a preservative-free solution), oxidation-resistant highly active proteins and other IL-33 related antibodies, proteins and assays.
The antibodies are reactive in thousands of plant and algal species, including Arabidopsis, cotton, cyanobacteria, grape, maize, Medicago, rice, soybean, sugar cane, tomato, wheat and more.
Researchers have used a portable analyser to detect anti-avian influenza virus antibody in blood serum within 20 minutes.
Antibodies for potential use as medicines can be made rapidly in chicken cells grown in laboratories.
COVID-19 Immunoglobulin will be developed using donations of plasma made in Australia by people who have recovered from COVID-19.
To join the fight against the 2019 novel coronavirus (COVID-19), MP Biomedicals now offers three monoclonal antibodies from mouse and five recombinant antigens for SARS-CoV-2, expressed in E. coli and HEK293.
ProteoGenix has announced its Human Immune COVID-19 library for the fast discovery of potent antibodies against SARS-CoV-2 — claimed to be a world first.
The highly specific and high-affinity antibodies are suitable for bioanalytical and patient drug level monitoring assays for the immune checkpoint inhibitor: ipilimumab.